Maria Godoy
👤 SpeakerAppearances Over Time
Podcast Appearances
Even so, an estimated 95,000 people, mostly children under age five, died from measles last year.
While that death toll is among the lowest in recent decades, WHO officials say it's still unacceptably high for a vaccine-preventable disease.
GLP-1 drugs have become increasingly popular among women of reproductive age, but women are advised to stop taking these medications before pregnancy because of potential risks to the fetus.
In the study, researchers from Mass General Brigham reviewed the medical records for nearly 1,800 pregnancies, primarily among women with obesity.
They found that women who stopped GLP-1 medications right before or early in pregnancy also had a higher risk of gaining excess weight, developing gestational diabetes, and hypertensive disorders compared to women who did not take these drugs.
The researchers say more studies are needed on the risks and benefits of taking GLP-1 drugs before having a baby.
GLP-1 drugs have become increasingly popular among women of reproductive age, but women are advised to stop taking these medications before pregnancy because of potential risks to the fetus.
In the study, researchers from Mass General Brigham reviewed the medical records for nearly 1,800 pregnancies, primarily among women with obesity.
They found that women who stopped GLP-1 medications right before or early in pregnancy also had a higher risk of gaining excess weight, developing gestational diabetes, and hypertensive disorders compared to women who did not take these drugs.
The researchers say more studies are needed on the risks and benefits of taking GLP-1 drugs before having a baby.
GLP-1 drugs have become increasingly popular among women of reproductive age, but women are advised to stop taking these medications before pregnancy because of potential risks to the fetus.
In the study, researchers from Mass General Brigham reviewed the medical records for nearly 1,800 pregnancies, primarily among women with obesity.
They found that women who stopped GLP-1 medications right before or early in pregnancy also had a higher risk of gaining excess weight, developing gestational diabetes, and hypertensive disorders compared to women who did not take these drugs.
The researchers say more studies are needed on the risks and benefits of taking GLP-1 drugs before having a baby.
The papers reviewed years' worth of evidence linking ultra-processed foods to poor health outcomes, including an increased risk of obesity, type 2 diabetes, cardiovascular disease, chronic kidney disease, Crohn's disease, and dying prematurely.
The researchers say ultra-processed foods have been shown to harm nearly all the organ systems in the human body.